IDEXX Laboratories PE Ratio 2010-2025 | IDXX
Current and historical p/e ratio for IDEXX Laboratories (IDXX) from 2010 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. IDEXX Laboratories PE ratio as of August 20, 2025 is 53.01.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| IDEXX Laboratories PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-08-20 | 639.85 | 53.28 | |
| 2025-06-30 | 536.34 | $12.01 | 44.66 |
| 2025-03-31 | 419.95 | $10.82 | 38.81 |
| 2024-12-31 | 413.44 | $10.67 | 38.75 |
| 2024-09-30 | 505.22 | $10.37 | 48.72 |
| 2024-06-30 | 487.20 | $10.10 | 48.24 |
| 2024-03-31 | 539.93 | $10.33 | 52.27 |
| 2023-12-31 | 555.05 | $10.07 | 55.12 |
| 2023-09-30 | 437.27 | $9.80 | 44.62 |
| 2023-06-30 | 502.23 | $9.42 | 53.32 |
| 2023-03-31 | 500.08 | $8.31 | 60.18 |
| 2022-12-31 | 407.96 | $8.03 | 50.80 |
| 2022-09-30 | 325.80 | $7.87 | 41.40 |
| 2022-06-30 | 350.73 | $7.75 | 45.26 |
| 2022-03-31 | 547.06 | $8.53 | 64.13 |
| 2021-12-31 | 658.46 | $8.61 | 76.48 |
| 2021-09-30 | 621.90 | $8.73 | 71.24 |
| 2021-06-30 | 631.55 | $8.39 | 75.27 |
| 2021-03-31 | 489.31 | $7.77 | 62.97 |
| 2020-12-31 | 499.87 | $6.71 | 74.50 |
| 2020-09-30 | 393.11 | $5.74 | 68.49 |
| 2020-06-30 | 330.16 | $5.29 | 62.41 |
| 2020-03-31 | 242.24 | $5.00 | 48.45 |
| 2019-12-31 | 261.13 | $4.88 | 53.51 |
| 2019-09-30 | 271.93 | $4.82 | 56.42 |
| 2019-06-30 | 275.33 | $4.63 | 59.47 |
| 2019-03-31 | 223.60 | $4.43 | 50.47 |
| 2018-12-31 | 186.02 | $4.27 | 43.56 |
| 2018-09-30 | 249.66 | $3.72 | 67.11 |
| 2018-06-30 | 217.94 | $3.46 | 62.99 |
| 2018-03-31 | 191.39 | $3.18 | 60.19 |
| 2017-12-31 | 156.38 | $2.94 | 53.19 |
| 2017-09-30 | 155.49 | $3.09 | 50.32 |
| 2017-06-30 | 161.42 | $2.92 | 55.28 |
| 2017-03-31 | 154.61 | $2.71 | 57.05 |
| 2016-12-31 | 117.27 | $2.45 | 47.87 |
| 2016-09-30 | 112.73 | $2.35 | 47.97 |
| 2016-06-30 | 92.86 | $2.21 | 42.02 |
| 2016-03-31 | 78.32 | $2.07 | 37.84 |
| 2015-12-31 | 72.92 | $2.05 | 35.57 |
| 2015-09-30 | 74.25 | $1.84 | 40.35 |
| 2015-06-30 | 64.14 | $1.88 | 34.21 |
| 2015-03-31 | 77.24 | $1.83 | 42.32 |
| 2014-12-31 | 74.14 | $1.78 | 41.65 |
| 2014-09-30 | 58.91 | $1.92 | 30.68 |
| 2014-06-30 | 66.78 | $1.84 | 36.39 |
| 2014-03-31 | 60.70 | $1.78 | 34.10 |
| 2013-12-31 | 53.19 | $1.74 | 30.57 |
| 2013-09-30 | 49.83 | $1.72 | 28.97 |
| 2013-06-30 | 44.84 | $1.67 | 26.85 |
| 2013-03-31 | 46.20 | $1.63 | 28.34 |
| 2012-12-31 | 46.40 | $1.59 | 29.27 |
| 2012-09-30 | 49.67 | $1.53 | 32.46 |
| 2012-06-30 | 48.06 | $1.48 | 32.47 |
| 2012-03-31 | 43.73 | $1.44 | 30.37 |
| 2011-12-31 | 38.48 | $1.39 | 27.68 |
| 2011-09-30 | 34.48 | $1.37 | 25.26 |
| 2011-06-30 | 38.78 | $1.33 | 29.27 |
| 2011-03-31 | 38.61 | $1.22 | 31.65 |
| 2010-12-31 | 34.61 | $1.19 | 29.21 |
| 2010-09-30 | 30.86 | $1.13 | 27.31 |
| 2010-06-30 | 30.45 | $1.10 | 27.68 |
| 2010-03-31 | 28.77 | $1.07 | 27.01 |
| 2009-12-31 | 26.73 | $1.01 | 26.60 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $50.940B | $3.898B |
| IDEXX Laboratories, Inc. is a developer, manufacturer and distributor of products and services primarily for the companion animal veterinary, livestock and poultry, water testing and dairy markets. The company also sells a series of portable electrolytes and blood gas analyzers for the human point-of-care medical diagnostics market. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $188.160B | 22.76 |
| Intuitive Surgical (ISRG) | United States | $171.782B | 71.20 |
| Edwards Lifesciences (EW) | United States | $46.340B | 30.71 |
| Alcon (ALC) | Switzerland | $44.451B | 29.84 |
| IQVIA Holdings (IQV) | United States | $32.700B | 18.48 |
| DexCom (DXCM) | United States | $31.725B | 47.59 |
| Mettler-Toledo (MTD) | United States | $27.244B | 32.34 |
| STERIS (STE) | Ireland | $24.388B | 25.96 |
| Waters (WAT) | United States | $17.722B | 24.34 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.000B | 0.00 |
| Hologic (HOLX) | United States | $15.084B | 16.34 |
| Penumbra (PEN) | United States | $9.875B | 72.14 |
| Sysmex ADR (SSMXY) | Japan | $8.416B | 26.74 |
| Globus Medical (GMED) | United States | $8.261B | 19.06 |
| Masimo (MASI) | United States | $7.973B | 26.83 |
| Teleflex (TFX) | United States | $5.493B | 8.87 |
| Glaukos (GKOS) | United States | $5.221B | 0.00 |
| TransMedics (TMDX) | United States | $4.182B | 63.56 |
| Integer Holdings (ITGR) | United States | $3.723B | 18.58 |
| LivaNova (LIVN) | United Kingdom | $2.920B | 16.71 |
| Alphatec Holdings (ATEC) | United States | $2.338B | 0.00 |
| Veracyte (VCYT) | United States | $2.326B | 32.14 |
| PROCEPT BioRobotics (PRCT) | United States | $2.210B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $2.118B | 25.29 |
| Artivion (AORT) | United States | $1.983B | 100.05 |
| Elekta AB (EKTAY) | Sweden | $1.850B | 17.30 |
| Integra LifeSciences Holdings (IART) | United States | $1.145B | 6.56 |
| OPKO Health (OPK) | United States | $1.080B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.067B | 0.00 |
| IRadimed (IRMD) | United States | $0.890B | 43.21 |
| Tandem Diabetes Care (TNDM) | United States | $0.736B | 0.00 |
| AxoGen (AXGN) | United States | $0.707B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.690B | 0.00 |
| SiBone (SIBN) | United States | $0.668B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.573B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.530B | 9.37 |
| OrthoPediatrics (KIDS) | United States | $0.480B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.472B | 3.79 |
| Treace Medical Concepts (TMCI) | United States | $0.454B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.390B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.386B | 9.82 |
| Delcath Systems (DCTH) | United States | $0.369B | 88.00 |
| RxSight (RXST) | United States | $0.360B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.359B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.297B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.287B | 19.78 |
| NeuroPace (NPCE) | United States | $0.273B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.265B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.229B | 0.00 |
| Neuronetics (STIM) | United States | $0.223B | 0.00 |
| 908 Devices (MASS) | United States | $0.222B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.215B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.214B | 0.00 |
| Inogen (INGN) | United States | $0.203B | 0.00 |
| CVRx (CVRX) | United States | $0.190B | 0.00 |
| Accuray (ARAY) | United States | $0.170B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.151B | 0.00 |
| LENSAR (LNSR) | United States | $0.149B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.141B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.132B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.108B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.108B | 0.00 |
| InspireMD (NSPR) | United States | $0.101B | 0.00 |
| Hyperfine (HYPR) | United States | $0.099B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.097B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.081B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.075B | 0.00 | |
| QT Imaging Holdings (QTIH) | United States | $0.063B | 0.00 |
| Positron (POSC) | United States | $0.058B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.056B | 22.67 |
| EDAP TMS S.A (EDAP) | France | $0.055B | 0.00 |
| Spectral AI (MDAI) | United States | $0.053B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.053B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.045B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.038B | 0.00 |
| Precision Optics (POCI) | United States | $0.036B | 0.00 |
| Envoy Medical (COCH) | United States | $0.026B | 0.00 |
| DarioHealth (DRIO) | United States | $0.020B | 0.00 |
| NexGel (NXGL) | United States | $0.019B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.019B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.016B | 0.00 |
| Tenon Medical (TNON) | United States | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.009B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.008B | 0.00 |
| ReShape Lifesciences (HIND) | United States | $0.006B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.001B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 13.22 |